Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures 1,5-anhydroglucitol, may be useful for...
A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes...
Precision Diabetes, Inc. and DxGen Corp. are pleased to announce that they have entered in an exclusive agreement in the U.S. to launch Epithod®...
Precision Diabetes, Inc. A new study recently published in Nature Metabolism shows that 1,5-anhydroglucitol (1,5-AG), a glucose-like metabolite,...
Precision Diabetes, Inc. today announces the presentation of data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate ...
Precision Diabetes, Inc. and Patia announced today results from a study showing that the GlycoMark blood test may be an effective marker of stress...
Precision Diabetes, Inc. (PDI), an emerging leader in precision diabetes diagnostics, announced results today from a study on its Precision IGT...
Patia Biopharma, SA, and Precision Diabetes, Inc. are pleased to announce they have entered into a global strategic alliance to transform the...
According to new data presented at the 56th European Association for the Study of Diabetes (EASD) annual meeting, the GlycoMark blood test reflects...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.